Selection of Bacillus anthracis isolates resistant to antibiotics
Open Access
- 1 July 2004
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Antimicrobial Chemotherapy
- Vol. 54 (2) , 424-428
Abstract
Objective: Long-term therapy for anthrax might induce antimicrobial resistance in Bacillus anthracis. The aim of the present study was to investigate the potential of 18 different antibiotics to select resistant isolates of B. anthracis, (ST-1 and Sterne strains). Methods: Resistant isolates were selected by serial passages on brain heart infusion agar containing increasing concentrations of antibiotics (from the MIC upwards). Results: The MICs of ciprofloxacin, ofloxacin and levofloxacin increased from 0.125–0.25 to 8 mg/L, that of moxifloxacin increased from 0.03–0.06 to 8 mg/L, in both strains, and the MIC of garenoxacin increased from 0.015 to 0.5 mg/L for the ST-1 strain and from 0.03 to 8 mg/L for the Sterne strain. The MICs of tetracycline and minocycline increased from 0.125 to 2–8 mg/L and 0.06 to 1 mg/L, respectively. The MIC of vancomycin increased from 2.5 to 20 mg/L for the ST-1 strain and from 5 to 20 mg/L for the Sterne strain. Linezolid exhibited an MIC increase from 2 to 4 mg/L for both strains. The MIC of quinupristin/dalfopristin increased from 0.125 to 64–128 mg/L. Erythromycin demonstrated an MIC increase from 1 to 128 mg/L, that of clarithromycin increased from 0.125 to 8–64 mg/L and that of telithromycin increased from 0.06–0.125 to 1–4 mg/L. The clindamycin MIC increased from 0.125–0.25 to 8 mg/L. Penicillin G and amoxicillin MICs increased from Conclusion: The ease with which B. anthracis can be made resistant in vitro suggests that close monitoring of patients treated for anthrax is mandatory.Keywords
This publication has 7 references indexed in Scilit:
- In Vitro Selection and Characterization of Bacillus anthracis Mutants with High-Level Resistance to CiprofloxacinAntimicrobial Agents and Chemotherapy, 2003
- Bacillus anthracis and antibacterial agentsClinical Microbiology and Infection, 2002
- Antibiotic Susceptibilities of 96 Isolates of Bacillus anthracis Isolated in France between 1994 and 2000Antimicrobial Agents and Chemotherapy, 2002
- Antimicrobial Susceptibility Testing of Bacillus anthracis : Comparison of Results Obtained by Using the National Committee for Clinical Laboratory Standards Broth Microdilution Reference and Etest Agar Gradient Diffusion MethodsJournal of Clinical Microbiology, 2002
- Molecular Analysis of Rifampin Resistance in Bacillus anthracis and Bacillus cereusAntimicrobial Agents and Chemotherapy, 2002
- In vitro resistance of Bacillus anthracis Sterne to doxycycline, macrolides and quinolonesInternational Journal of Antimicrobial Agents, 2001
- In Vitro Development of Resistance to Ofloxacin and Doxycycline in Bacillus anthracis Sterne Antimicrobial Agents and Chemotherapy, 2000